Oyster Point Pharma, Inc. Accounts Receivable
Oyster Point Pharma, Inc. had Accounts Receivable of $13.18 million as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2022-11-10
- 2022-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $13.18M.
- 2022-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $10.92M.
- 2022-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $5.74M.
- 2021-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $6.66M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2022-09-30 | $13.18M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $10.92M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $5.74M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $6.66M 10-Q · filed 2022-11-10 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-24 |